Table 1. Baseline Demographic Information and Clinical Characteristics of Participants.
| Characteristic | No. (%) | |
|---|---|---|
| Berdazimer gel, 10.3% (n = 444) | Vehicle (n = 447) | |
| Age, mean (range), y | 6.6 (0.9-47.5) | 6.5 (1.3-49) |
| Sex | ||
| Male | 228 (51.4) | 213 (47.7) |
| Female | 216 (48.6) | 234 (52.3) |
| Race and ethnicity | ||
| Asian | 6 (1.4) | 6 (1.3) |
| Black or African American | 21 (4.7) | 28 (6.3) |
| Hispanica | 94 (21.2) | 87 (19.5) |
| Otherb | 30 (6.8) | 31 (6.9) |
| White | 387 (87.2) | 382 (85.5) |
| Baseline lesion count, mean (range) | 23.1 (3-70) | 20.5 (3-69) |
| Baseline BOTE scorec | ||
| 0 (no inflammation) | 225 (50.7) | 223 (49.9) |
| ≥1 (mild to very severe) | 219 (49.3) | 224 (50.1) |
| Age at awareness of lesions, median (range), y | 4.8 (0.2-46.9) | 4.9 (0-37.3) |
| Months since awareness of lesions, mean (range) | 12.0 (0.2-153.3) | 13.1 (0-192.8) |
| Patients randomized per householdd | ||
| 1 Patient | 403 (90.8) | 406 (90.8) |
| 2 Patients | 41 (9.2) | 41 (9.2) |
Abbreviation: BOTE, beginning-of-the-end.
a
Individuals of Hispanic and Latino ethnicity are also included in the numbers by race because race and ethnicity were treated separately for data collection.
b
Includes American Indian, Alaska Native, Native Hawaiian, other Pacific Islander, more than 1 race, and not reported.
c
Average for all lesions.
d
Percentages based on total number of households.